fda compounding semaglutide enforcement news november 2025 GLP-1 Weight Loss Drug in 2025: State Attorneys General Step into a Growing Regulatory Gap Compounded Semaglutide: Safety & Regulation

Step 5: Monitor for reactions After injecting, look for redness, swelling, or an allergic reaction like a rash or difficulty breathing

GLP-1 receptor agonists mimic the gut hormone GLP-1 to stimulate insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite

FDA prescribing information for GLP-1 medications does not list generalized skin sensitivity or heightened skin reactivity as recognized adverse effects

Blood Sugar Control : For people with Type 2 diabetes, controlling blood sugar levels is essential for a healthy pregnancy

With a focus on women's healthcare, Hers is a telehealth platform that connects users with specialized healthcare services

Clinical implication The potential ocular complications associated with GLP-1 RAs need careful clinical consideration